FDA Update! 14 Classes of Class II Toxicology Testing Systems Qualify for 510(k) Exemption! - Wiselink Group-A More Controllable, Stable, and Future-Oriented Material Direction

Home > News Center > FDA Update! 14 Classes of Class II Toxicology Testing Systems Qualify for 510(k) Exemption!

FDA Update! 14 Classes of Class II Toxicology Testing Systems Qualify for 510(k) Exemption!

Time：2026-10-10 13:44:34

On 6 October 2026, FDA issued a final rule expanding the 510(k) exemption scope for 14 types of Class II clinical toxicology (drug abuse) testing systems. Previously excluded federal drug testing applications are now covered under the exemption. This is a major benefit for manufacturers of related test kits, subject to strict limitations. Products outside the scope still require 510(k) submission.

原

文

链

接

https://www.fda.gov/medical-devices/classify-your-medical-device/class-i-and-class-ii-device-exemptions

一、Background of the Change

Prior to this amendment, these 14 types of Class II drug abuse test kits were only eligible for 510(k) exemption when used for employment and insurance screening applications. For use in federal drug testing programs (e.g., DOT Department of Transportation, SAMHSA Substance Abuse and Mental Health Services Administration, US military and other mandatory federal drug testing), exemption was unavailable and manufacturers were required to submit a 510(k) for market clearance.

This final rule removes this exception: eligible testing systems used even within federal drug testing programs may benefit from 510(k) exemption, effective immediately. Manufacturers no longer need to allocate resources for 510(k) submission, cutting time and costs for market access.

二、Core Updates

（一）14 Product Categories Included in the Expanded Exemption

Important Note: Fentanyl detection systems fall under opiate test systems and qualify for this expanded exemption.

（二）Two Mandatory Criteria to Qualify for Exemption

Intended Use Restriction：The product shall be limited to employment and insurance screening scenarios. Even when used in federal drug testing programs, this core intended use cannot be altered. If the product is claimed for clinical disease diagnosis or patient treatment decision-making, exemption eligibility is forfeited and a 510(k) is still required.

Labeling Statement Requirement：The product label or instructions for use must state that the device is solely for employment and insurance testing. FDA does not mandate fixed wording, but the statement must convey this intent. Products retaining outdated labeling cannot automatically claim this exemption; FDA will not exercise enforcement discretion for such cases.

（三）General Exemption Boundaries (21 CFR 862.9, applicable to all exempt products)

Exemption is invalid and a 510(k) must be submitted if any of the following apply:

Intended use differs from legally marketed predicate devices of the same type
Completely different underlying scientific and technical principles are adopted
Major changes to product characteristics that materially increase risks of misdiagnosis or harm

Example: For the same opiate test kit, if the core detection principle is modified, exemption no longer applies even when the target analyte remains unchanged.

三、Clarification of Responsibilities between FDA and SAMHSA

Many manufacturers confuse these two regulatory frameworks:

FDA: Regulates the medical device nature of test kits. This update concerns 510(k) exemption at the FDA level.
SAMHSA/NLCP: Responsible for laboratory certification and mandatory laboratory operating guidelines for federal drug testing programs.

FDA 510(k) exemption ≠ automatic qualification for SAMHSA laboratory access. While the test kit may be exempt from 510(k), compliance with mandatory SAMHSA requirements remains required for use in federal programs. The two systems are independent and cannot be equated.

四、General Logic for FDA 510(k) Exemption for Class I / Class II Devices

FDA’s overarching regulatory framework：

Class I Devices：Most are exempt from 510(k); a small subset of high-risk Class I devices are non-exempt.

Class II Devices：510(k) submission is required in principle. Exemption is only available when explicitly listed in FDA Federal Register / regulations. This rule is a typical example of expanded exemption for Class II devices.

Sources of exemptions：early pre-amendment devices, and exemptions under the 21st Century Cures Act. FDA periodically updates exemption inventories via Federal Register notices.

How to verify：Search the FDA Product Classification database for the corresponding Product Code, and review §xxx.9 of the regulation to understand all applicable limitations.

Major product changes require reassessment of exemption status; eligibility is not permanent upon a single review.

五、Conclusion

This rule brings substantial benefits for Chinese manufacturers of drug abuse test kits exporting to the US, eliminating the time and financial costs associated with 510(k) submission. However, this only waives pre-market review requirements and does NOT reduce compliance obligations for product quality, labeling, or device registration listing.For further enquiries, please contact Wiselink Group!

Previous：Must-Know Guide: UKCA Marking for Medical Devices in 2026 – Key FAQs & Essentials Next：EU CE: Multiple Core Standards Updated in 2026, Immediate Self-Review Required for MDR Technical Documentation

Fill Form

Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.